My bookmarksSign up free

Commission Implementing Decision (EU) 2026/197 of 28 January 2026 amending Implementing Decision (EU) 2021/1195 as regards harmonised standards for sterilization of health care products and information supplied by the manufacturer (labelling)

Commission Implementing Decision (EU) 2026/197 of 28 January 2026 amending Implementing Decision (EU) 2021/1195 as regards harmonised standards for sterilization of health care products and information supplied by the manufacturer (labelling)

Implementing Decision (EU) 2026/197 · Decision · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

The Annex to Implementing Decision (EU) 2021/1195 is amended in accordance with the Annex to this Decision.

Article 2

This Decision shall enter into force on the day of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

ANNEX In the Annex to Implementing Decision (EU) 2021/1195, the following entries are added: No Reference of the standard ‘18. EN ISO 17665:2024 Sterilization of health care products - Moist heat - Requirements for the development, validation and routine control of a sterilization process for medical devices (ISO 17665:2024) 19. EN ISO 18113-1:2024 In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 1: Terms, definitions, and general requirements (ISO 18113-1:2022) 20. EN ISO 18113-2:2024 In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 2: In vitro diagnostic reagents for professional use (ISO 18113-2:2022) 21. EN ISO 18113-3:2024 In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 3: In vitro diagnostic instruments for professional use (ISO 18113-3:2022) 22. EN ISO 18113-4:2024 In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 4: In vitro diagnostic reagents for self-testing (ISO 18113-4:2022) 23. EN ISO 18113-5:2024 In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 5: In vitro diagnostic instruments for self-testing (ISO 18113-5:2022)’.

Other acts of the same type
Commission Implementing Decision (EU) 2021/182 of 12 February 2021 setting out the breakdown by Member State of REACT-EU resources for the year 2021 (notified under document C(2021) 843)Commission Implementing Decision (EU) 2021/183 of 12 February 2021 amending Implementing Decision (EU) 2017/2453 as regards the authorisation holder and its representative in the Union for the placing on the market of products containing, consisting of or produced from certain genetically modified oilseed rapes (notified under document C(2021) 823) (Only the Dutch and German texts are authentic) (Text with EEA relevance)Commission Implementing Decision (EU) 2021/184 of 12 February 2021 amending Decisions 2009/813/EC, 2009/814/EC and 2010/429/EU and Implementing Decisions 2012/82/EU, 2012/83/EU, 2012/347/EU, 2013/649/EU, (EU) 2015/683, (EU) 2015/684, (EU) 2015/685, (EU) 2015/686, (EU) 2015/687, (EU) 2015/688, (EU) 2015/689, (EU) 2015/693, (EU) 2015/695, (EU) 2015/696, (EU) 2015/700, (EU) 2015/701, (EU) 2015/2279, (EU) 2015/2281, (EU) 2016/1216, (EU) 2016/1217, (EU) 2017/1207, (EU) 2018/1111, (EU) 2018/2045, (EU) 2018/2046, (EU) 2019/1307, (EU) 2019/1308, (EU) 2019/1309, (EU) 2019/2083 and (EU) 2020/1360 as regards the authorisation holder and its representative in the Union for the placing on the market of products containing, consisting of or produced from certain genetically modified organisms (notified under document C(2021) 826) (Only the Dutch text is authentic) (Text with EEA relevance)Commission Implementing Decision (EU) 2021/260 of 11 February 2021 approving national measures designed to limit the impact of certain diseases of aquatic animals in accordance with Article 226(3) of Regulation (EU) 2016/429 of the European Parliament and of the Council and repealing Commission Decision 2010/221/EU (notified under document C(2021) 773) (Text with EEA relevance)Decision (EU) 2021/174 of the European Central Bank of 10 February 2021 amending Decision (EU) 2020/440 on a temporary pandemic emergency purchase programme (ECB/2021/6)Commission Decision (EU, Euratom) 2021/259 of 10 February 2021 laying down implementing rules on industrial security with regard to classified grantsCommission Decision (EU) 2021/156 of 9 February 2021 renewing the mandate of the European Group on Ethics in Science and New TechnologiesCommission Decision (EU) 2021/143 of 5 February 2021 amending the Annex to the Monetary Agreement between the European Union and the Vatican City StateCommission Decision (EU) 2021/144 of 5 February 2021 updating Annex A to the Monetary Agreement between the European Union and the Principality of MonacoCommission Decision (EU) 2021/145 of 5 February 2021 amending the Annex to the Monetary Agreement between the European Union and the Republic of San MarinoCommission Decision (EU) 2021/146 of 5 February 2021 amending the Annex to the Monetary Agreement between the European Union and the Principality of AndorraCouncil Decision (EU) 2021/176 of 5 February 2021 on the conclusion of the amendments to the Agreement for cooperation in dealing with pollution of the North Sea by oil and other harmful substances (Bonn Agreement) with regard to the extension of the scope of application of that Agreement and on the accession of the Kingdom of Spain to that Agreement

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next